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Cervical carcinogenesis is a complex problem with papillomavirus widely accepted as a causa-
tive agent. Integration of a human papillomavirus (HPV) of the high-risk type into the host 
cell genome is one of the major contributing factors to cervical malignant transformation. In 
this study, the correlation of CMV, EBV, HSV-1, HSV-2, HHV-6 and HHV-7 infections with the 
physical status of the HPV genome in cervical cancer and precancerous cervical lesions was in-
vestigated in sixty HPV-16-positive women. Cervical secretion samples were submitted to DNA 
extraction and analyzed by PCR. HPV-16 DNA was confirmed in genotyping with the reverse 
hybridization line probe assay. Multiplex PCR with specific primers for the E2/E6 genes was 
used to assess the viral integration status of HPV-16. Our results show that CMV DNA was 
more frequently present in samples with mixed forms of HPV-16 than in the episomal form 
(P < 0.025). Such a correlation was also observed in the case of EBV (P < 0.005). The presence of 
CMV resulted in a six-fold (OR 6.069; 95% CI 1.91–19.22; P = 0.002), while EBV caused a seven-
fold (OR 7.11; 95% CI 1.70–29.67; P = 0.007) increase in the risk of the integrated or mixed HPV-
16 genome occurrence. Our data suggest that coinfection with herpesviruses, especially CMV 
and EBV, may be involved in the integration of the HPV-16 genome and may contribute to the 
development of cervical cancer. 
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INTRODUCTION
HPV is the most prevalent sexually transmit-
ted disease which occurs commonly in young wom-
en. Primary infection of this virus often regresses 
spontaneously, but prolonged, persistent infection, 
especially with HPV types showing a strong asso-
ciation with malignant lesions, leads to viral inte-
gration with the host cell genome and expression of 
the viral oncogenes E6 and E7 (zur Hausen, 2002). 
Sexually active women have a 75% lifetime risk of 
contracting HPV and 5.5 million women worldwide 
contract HPV each year. However, 80% of females 
infected with HPV will clear the virus from their 
bodies within 12 to 18 months. For every 1 million 
women infected, 100 000 will have precancerous 
changes in their cervical tissue. Of these, carcinoma 
in situ will develop in about 8 000, and invasive can-
cer will develop in about 1 600 (Matias, 2004; Scheu-
rer et al., 2005). 
Papillomavirus infection occurs before the de-
velopment of the malignancy, but the process of car-
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cinogenesis depends on a number of other factors, 
such as the kind of HPV genotype, the duration of 
infection, patient age, possible hormonal abnormali-
ties, the efficacy of the immune system, the presence 
of mutations in the genome of the host, and the in-
cidence of concomitant infections. Apart from Herpes 
simplex virus, which has long been suspected to act 
as a cofactor in the development of cervical cancer, 
other herpesviruses are also potential candidates. 
As early as in the 1960s and 70s, attention 
was focused on the two- to three-fold higher risk of 
cervical cancer development in women having spe-
cific antibodies against Herpes simplex virus type 2 
(HSV-2) compared to seronegative females (Rawls et 
al., 1968). Experiments carried out in vitro on induc-
tion of neoplastic transformation of HPV-immortal-
ized human cervical epithelial cells using the Xho2 
sequence of the HSV-2 virus genome demonstrated 
such an association (DiPaolo et al., 1998). Successful 
attempts were also undertaken to induce dysplastic 
and neoplastic lesions in the cervix of mice follow-
ing experimental infection with inactivated human 
cytomegalovirus (CMV) (Heggie et al., 1986). The 
immediate-early gene products of CMV can transac-
tivate other viral and cellular genes, and it has been 
suggested that concurrent genital infection with 
CMV and HPV might increase the risk of cervical 
cancer. 
On the other hand, Epstein-Barr virus (EBV), 
which is responsible for the development of lym-
phomas (Burkitt’s lymphoma, Hodgkin’s lymphoma, 
T lymphocyte lymphoma) and nasopharyngeal carci-
noma, is also taken into account in etiopathogenesis 
of  gastric and mammary gland carcinomas (Vo et 
al., 2002; Glaser et al., 2004). 
Among the 120 types of HPVs discovered 
to date, about 40 are involved in anogenital infec-
tions. Epidemiological and biochemical data sup-
port the division of HPVs into two groups: high-
risk, such as HPV-16, 18, 31, 33, 35, 39, 45, 51, 
52, 56, 58, 59, 68, 73, and 82, capable of causing 
progression to cancer of the uterine cervix, and 
low-risk, such as HPV-6, 11, 40, 42, 43, 44, 54, 61, 
70, 72, and 81, rarely, if ever, leading to cancer. 
HPV-16 is the most extensively studied HPV type 
and serves as an important model for studying vi-
ral carcinogenesis. The E6 and E7 genes of high-
risk HPVs are known to play an important role 
in cervical carcinogenesis because they are highly 
expressed in cervical carcinoma cells and have 
the ability to transform and immortalize primary 
keratinocytes. In the process of inactivation of tu-
mor-suppressor gene products, E6 proteins lead 
to the degradation of p53 protein, and the bind-
ing complex of E7 and pRB proteins disturbs the 
normal cell cycle and leads to abnormal cellular 
proliferation (zur Hausen, 2002).
During a common infection and in most pre-
malignant lesions, HPV is in an episomal state. How-
ever, most cervical carcinomas and derived cell lines 
maintain the HPV genome in an integrated form or 
in both integrated and episomal forms. Thus, inte-
gration of the viral genome into the chromosomes 
of the host cell has been proposed as an activation 
mechanism for progression from preinvasive lesions 
to cervical cancer. The genome integration of HPV 
usually disrupts or deletes the E2 gene open reading 
frame, or rarely the E1 open reading frame, which 
results in the loss of expression of the correspond-
ing gene products. Disruption of these genes also 
leads to overexpression of the E6 and E7 oncopro-
teins, since the E2 gene products repress the activi-
ties of the HPV promoters that direct the expression 
of the E6 and E7 genes. The disruption of the E2 
gene upon viral genome integration will make this 
gene sequence impossible to PCR amplification (zur 
Hausen 2000; Schmidt et al., 2005; Howley & Lowy, 
2007).
The objective of the present study was to in-
vestigate the correlation of infection with selected 
viruses from the Herpesviridae family (CMV, EBV, 
HSV-1, HSV-2, HHV-6 and HHV-7) with the physi-
cal status of HPV-16 in cervical cancer and precan-
cerous cervical lesions. 
MATERIALS AND METHODS
Cervical smears with HPV-16, confirmed by 
genotyping, were obtained from 60 women (20–75 
years; mean 36 ± 15 years) with different clinical di-
agnoses: low grade squamous intraepithelial lesions 
— LSIL (n = 27), high grade squamous intraepithe-
lial lesions — HSIL (n = 10), and cervical carcinoma 
(n = 23, FIGO IIa/IIb). The specimens were collected 
to saline solution and stored frozen at –70oC until 
processed. 
Genomic DNA was isolated using the Genom-
ic DNA Prep Plus kit (A&A Biotechnology, Poland). 
Viral DNA detection. Viral DNA detection 
was performed using PCR according to previous-
ly published methods (Szostek et al., 2006; 2008a; 
Zawilińska et al., 2006; 2008). Each experiment was 
performed with positive and negative (H2O) PCR 
controls. Targets for primers are shown in Table 1. 
To ensure adequate DNA preparation, PCR ampli-
fication of β-actin gene was performed in a separate 
reaction (Guzik et al., 1999). The PCR products were 
visualized electrophoretically in 2% agarose gels.
HPV-16 genotyping. Broad-spectrum HPV 
DNA amplification was performed using the SPF-
10 primers designed by Innogenetics and amplified 
a 65-bp fragment from the L1 region of the HPV 
genome. PCR products were typed with reverse 
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hybridization in the INNO-LiPA HPV genotyping 
assay (Innogenetics, Gent, Belgium). After hybrid-
ization of the PCR product to probes on the strip, 
hybrids were detected in enzymatic reaction with al-
kaline phosphatase/streptavidin conjugate and sub-
strate (5-bromo-4-chloro-3-indolylphosphate and ni-
troblue tetrazolium) according to the manufacturer’s 
instructions. 
Determination of physical status of HPV-16 
DNA. Multiplex PCR with specific primers for the 
E2/E6 genes (Yoshinouchi et al., 1999) was used to 
assess the integration status of HPV-16. The primers 
for each sequence were:
5’-CTTGGGCACCGAAGAAACAC-3’,
5’-TTGGTCACGTTGCCATTCAC-3’ for the E2 gene 
and
5’-AAGGGCGTAACCGAAATCGGT-3’,
5’-CATATACCTCACGTCGCAG-3’ for the E6 gene.
The amplimer sizes were 352 bp and 208 bp 
for the E2 and E6 sequences, respectively. PCR was 
performed according to the previously described 
procedure (Szostek et al., 2008b). Transilluminated 
gel images were digitalized and analyzed by a Gel 
Doc 2000 documentation system (Bio-Rad, USA). 
The values corresponding to the intensity and den-
sity of the gel bands of different PCR products 
were obtained with the help of Quantity One 4.0 
software (Bio-Rad, USA). The ratio of E2 to E6 copy 
numbers was calculated to determine the physical 
status of the HPV-16 genome. HPV-16 in a pure 
episomal form was expected to have equivalent 
copy numbers of the E2 and E6 genes (E2/E6 ra-
tio ≥ 1), whereas preferential disruption of E2 upon 
viral integration should have resulted in fewer E2 
than E6 gene copies. This means that an E2/E6 ratio 
of less than 1 would indicate the presence of both 
the integrated and episomal forms, while a ratio of 
“0” would indicate the presence of the integrated 
form only. 
Statistics. The incidence 
rates of infection in the cervical 
smear abnormality groups were 
compared using the Fisher exact 
test. The Kruskall-Wallis test was 
used to compare age in the stud-
ied groups. The relative risk (odds 
ratio) of the type of HPV-16 physi-
cal status through herpesviruses 
infection was adjusted to age and 
assessed using the multivariate lo-
gistic regression. The analyses were 
carried out using the STATA 8.0 
software package. 
RESULTS AND DISCUSSION
The long latency between HPV 
infection and development of cervical cancer plus 
the low prevalence of cervical cancer relative to the 
number of women positive for HPVs suggest that 
other etiologic agents and cellular factors are in-
volved in the progression to malignancy. In our cur-
rent studies we investigated the correlation of infec-
tion with selected viruses from the Herpesviridae fam-
ily (CMV, EBV, HSV-1, HSV-2, HHV-6 and HHV-7) 
with the physical status of HPV-16 in cervical cancer 
and precancerous cervical lesions.  
In the 60 cervical HPV-16-positive samples 
studied, 72% cases with herpesvirus coinfections 
were detected. Among them CMV was detected in 
52% of the samples, EBV in 22%, HHV-7 in 14.5%, 
HHV-6 in 10%, HSV-1 in 5% and HSV-2 in 4%. In 
43 women with confirmed herpesvirus coinfections, 
60% were infected with a single herpesvirus. CMV 
DNA was the most frequently observed (61.5%), 
followed by EBV (15%), HHV-7 (11.5%), HHV-6 
(7.6%), and HSV-1 (3.8%). The presence of two her-
pesviruses was noted in sixteen HPV-16-positive 
samples (37%); of this group, CMV and EBV were 
detected in 50% of cases, CMV and HHV-6 — in 
19%, CMV and HHV-7 — in 12.5%, while CMV and 
HSV-1 or HSV-1 and HSV-2 or HSV-2 and HHV-7 
— in 6%. Triple infection (CMV, EBV and HHV-7) 
was detected in one patient only; the woman was 
diagnosed with cervical cancer. The incidence of 
herpesvirus DNA depending on the clinical diag-
nosis is presented in Fig. 1. We found significant 
differences in CMV or EBV incidence depending 
on the stage of the disease. The presence of CMV 
or EBV DNA was more frequent in cervical cancer 
specimens than in other study groups (P < 0.004 and 
P < 0.006, respectively). No such correlations were 
noted in the case of the remaining herpesviruses 
(HSV, HHV-6, HHV-7), although other authors sug-
gested their involvement (Romano et al., 1996; Broc-
Table 1. Detected viruses in analyzed samples.
Virus Region According to: Positive control
HPV L1 Kleter et al., 1998 CaSki cells*
CMV gB Mitchell et al., 1994 MRC-5 cell line**
EBV EBNA 2 Venard et al., 2000 Namalwa cells***
HSV-1 HSV-2 gD Cassinotti et al., 1996 RK-13 cell line****
HHV-6 U42
Chan et al., 1997
Clinical isolate of viral DNA
HHV-7 U42 Clinical isolate of viral DNA
*CaSki cells contain about 600 copies of integrated HPV-16; **MRC-5 cell line infected 
with CMV-AD 169 strain; ***Namalwa cells contain two copies of EBV DNA incorpo-
rated into the genome; ****RK-13 cell line infected with references strains of HSV-1 and 
HSV-2 (McIntyre and MS respectively).
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colo et al., 2008). Although recent reports describing 
investigations carried out in Italy do not confirm a 
direct correlation between CMV and the process of 
cervical oncogenesis, they indicate a possible coop-
eration of cytomegalovirus and another herpesvi-
rus, HHV-6, in development of intraepithelial cer-
vical lesions (Broccolo et al., 2008). The mechanism 
of cellular transformation with an involvement of 
CMV might be associated with expression of early 
viral proteins IE1 and IE2, which were proven to be 
mutagenic in an animal model (Shen et al., 1997). 
The advocates of the „hit and run” theory believe 
cytomegalovirus to be a transformation-initiating 
factor and they explain problems with direct detec-
tion of this infection in carcinoma cells by elimi-
nation of viral DNA in the course of oncogenesis 
(Lanham et al., 2001). In turn, based on compara-
tive studies carried out in patients infected with 
highly oncogenic HPV types and in HPV-negative 
females, British authors suggest that CMV, HHV-6 
and HHV-7 only coexist in the cervical epithelium 
rather than being cofactors involved in carcinogen-
esis (Chan et al., 2001). On the other hand, the role 
of EBV virus in oncogenesis of cervical carcinoma 
may be associated, among others with an increased 
expression of the viral LMP-1 and EBNA-2 genes 
which have been attributed a role in transformation 
of human B lymphocytes (Sasagawa et al., 2000). 
Of some significance may also be the presence of 
methylated regions of host regulatory gene promot-
ers in cells infected with the HPV and EBV viruses 
(Kim et al., 2005; Lattario et al., 2008).
The integration of high-risk human papillo-
mavirus (HPV) into the host cell genome is one of 
the major contributing factors to cervical malignant 
transformation (Kulmala et al., 2006; Huang et al., 
2008). In our study, in all the HPV-16-positive sam-
ples examined, the physical status of the virus was 
identified by multiplex PCR with specific primers 
for the E2 and E6 genes. Figure 2 shows the episom-
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Figure 1. Frequency of DNA of herpesviruses in HPV-
16-positive women with different clinical diagnoses.
It can be observed that CMV and EBV DNA was more 
frequent in cervical cancer (Ca) specimens than in LSIL 
group (P < 0.004) and HSIL group (P < 0.006).
Figure 2. Representative gel showing PCR products for 
E2/E6 HPV-16 genes obtained using multiplex PCR.
Samples were collected from women with different states 
of intraepithelial cervical lesions. MW, molecular size 
marker 100–500 bp; lane 1, negative control (H2O); lane 2, 
two PCR products with similar density which represent 
episomal form of HPV-16, sample from patient with LSIL; 
lane 3, PCR product for E6 HPV-16 only which is indica-
tive of integrated form, sample from patient with cervi-
cal carcinoma; lane 4, more intensive PCR product for E2 
HPV-16 than for E6 gene which is accepted as an episomal 
form, sample from patient with LSIL; lane 5, PCR product 
for E2 HPV-16 with lower density than PCR product for 
E6 HPV-16, pattern characteristic for mixed (episomal and 
integrated) form, sample from patient with HSIL.
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Figure 3. Frequency of distribution of CMV and EBV 
DNA in patients with different HPV-16 DNA physical 
states.
CMV and EBV DNA were more frequently present in 
samples with the integrated and mixed forms of HPV-16 
(P < 0.005).
Table 2. Correlation between physical status of  HPV-16 
DNA and cytological diagnoses.
Physical status of HPV-16 DNA
Cytology n Episomal
E2/E6≥1
Episomal  
and integrated
1>E2/E6>0
Integrated
E2/E6=0
LSIL 27 26 1 0
HSIL 10 9 1 0
Ca* 23 0 17 6
Total 60 35 (58%) 19 (32%) 6 (10%)
Ca*, cervical carcinoma
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al, integrated and mixed forms based on an analysis 
of the ratio of PCR products specific for E2 and E6 
of HPV-16.
Only the free episomal form of HPV-16 was 
seen in 58% samples and predominated in the 
LSIL group (Table 2). Ten percent of samples har-
bored the integrated form, whereas a mixture of 
the episomal and integrated forms of viral DNA 
was confirmed in 32% of the studied samples. 
The integrated form of HPV-16 DNA was pres-
ent in all the cervical cancer specimens and was 
correlated with progression of cytological chang-
es. Therefore, the most important aspect of our 
study was examining the relationship between the 
physical status of the HPV-16 genome and herpes-
virus coinfections. This correlation is presented in 
Table 3 and Fig. 3 for CMV and EBV viruses only, 
because for the remaining herpesviruses (HSV, 
HHV-6, and HHV-7), such a correlation was not 
statistically significant (not presented). CMV DNA 
was more frequently present in the samples with 
the integrated or mixed forms of HPV-16 than 
in those with the episomal form alone (P < 0.005) 
(Fig. 3). Such correlation was also observed in 
the case of EBV (P < 0.005). A multivariate logis-
tic regression analysis showed that the presence 
of CMV was correlated with a six-fold (OR 6.069; 
95% CI 1.91–19.22; P = 0.002), while EBV seven-fold 
(OR 7.11; 95% CI 1.70–29.67; P = 0.007) increase in 
the probability of the occurrence of the integrated 
or mixed HPV-16 genome. Our data suggest that 
coinfection with herpesviruses, especially CMV 
and/or EBV, may be involved in integration of the 
HPV-16 genome and may contribute to the devel-
opment of cervical cancer. 
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